Tag: NYSEMKT:ERB

Finance

Shining on Major News : Amgen Inc. (NASDAQ:AMGN), Digi International Inc. (NASDAQ:DGII), Meritage Homes Corporation (NYSE:MTH), ERBA Diagnostics, Inc. (NYSEMKT:ERB), WESCO International (NYSE:WCC)

On SEP 5, Amgen Inc. (NASDAQ:AMGN) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2014, at the Grand Hyatt New York in New York City, beginning at 9:10 a.m. ET. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference.  Amgen Inc. (NASDAQ:AMGN) belongs to Healthcare sector. Its net profit margin is 25.70% and weekly … Continue reading Shining on Major News : Amgen Inc. (NASDAQ:AMGN), Digi International Inc. (NASDAQ:DGII), Meritage Homes Corporation (NYSE:MTH), ERBA Diagnostics, Inc. (NYSEMKT:ERB), WESCO International (NYSE:WCC)

Mark DeFrance
Finance

Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)

Cara Therapeutics Inc (NASDAQ:CARA) — which has a preclinical cannabis compound — jumped 11.58%. The company is clearly running (smoke) rings around the competition and has the most appropriately named spokeswoman on Earth should it wish to employ the English supermodel as a mouthpiece. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was -7.49% in last session and finished the day at $14.20. Traded volume was 123,773.00million … Continue reading Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)

Richard Atkins